Welcome to our dedicated page for MARIJUANA news (Ticker: MAJI), a resource for investors and traders seeking the latest updates and insights on MARIJUANA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MARIJUANA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MARIJUANA's position in the market.
Marijuana Inc. (OTCPINK: MAJI) has acquired 100% of Exousia AI in a cash and stock transaction, issuing 47 million restricted shares to Ludwig Enterprises with specific lock-up features tied to NASDAQ uplisting. The deal includes assuming liabilities under $75,000 and a $100,000 note.
The acquisition brings worldwide licensed technology for plant-based and human-derived exosomes, including ongoing studies for Glioblastoma treatment and planned studies in dermatology and dental markets. The company will manufacture and sell exosomes for nutraceutical and dermatology markets, targeting the rapidly growing cosmeceuticals sector.
The exosome skincare market is projected to grow from $310 million in 2025 to $633 million in 2033, with a 10% compound annual growth rate. A 30-day treatment currently sells for $400 per vial. The company plans to expand its oncology studies and potentially license its technology to drug manufacturers for enhanced chemotherapy treatments.